Why LienScripts Was Built by Pharmacists Who Lived the Problem

James Wong — Founder & Pharmacist, LienScripts | December 17, 2025 | 6 min read

James Wong was a practicing pharmacist when he was injured in a car accident and couldn't access his medications. That gap is why LienScripts exists.

What Most Pharmacy Lien Providers Get Wrong

Most pharmacy lien programs were not built by pharmacists. They were built by financial engineers — people who looked at the personal injury industry, recognized that medication access was an unsolved problem, and designed a product to capture that revenue. The result is a category dominated by card processors: companies whose core offering is a card that injured patients carry to a retail pharmacy, and whose business model is acquiring and holding the resulting lien.

That model optimizes for something specific: volume. Cards are easy to issue. Enrollments are easy to track. The patient's experience — whether they can actually get their medication, whether they can drive to a pharmacy, whether the pharmacist on duty can answer a clinical question — is somebody else's problem.

[!KEY] Most pharmacy lien providers have never been the injured patient who couldn't fill their prescription. At LienScripts, one of our founders has. That changes everything about how we built this.

James Wong: The Pharmacist Who Became the Patient

James Wong, PharmD, was a practicing pharmacist when he was injured in a car accident. He knew the system from the inside — the pharmacy workflow, the insurance authorization process, the clinical protocols. He knew what a pharmacy was supposed to be able to do.

And he still couldn't access his medications.

The barriers weren't about knowledge. They were structural: transportation limitations from his injuries, insurance complications, a system that assumed patients could navigate it independently in the middle of managing acute pain and restricted mobility. James was a pharmacist. If he was struggling, patients without clinical training were facing something far worse.

That experience is the origin of LienScripts. Not a market analysis. Not a gap in the competitive landscape. A person who lived the problem and knew exactly what a better solution looked like.

[!KEY] When you've been the patient who couldn't get their medication after an accident, you build the service differently. You think about transportation first. You think about what happens when the client can't drive.

What Clinical Pharmacy Expertise Changes

Amar Lunagaria, PharmD, joined as Co-Founder and Chief Pharmacist. His background is clinical pharmacy — the side of the profession that manages complex medication regimens, navigates drug interactions, and communicates with prescribers on behalf of patients.

In a personal injury context, that clinical expertise has direct, practical consequences.

Personal injury cases frequently involve polypharmacy — multiple prescriptions from multiple providers. A patient may have a primary care physician managing their baseline medications, an orthopedist prescribing post-surgical pain management, and a neurologist treating nerve damage. Each provider knows their piece. No one has the complete picture. A pharmacist does.

At LienScripts, every prescription is reviewed by a licensed pharmacist — not routed through an automated card processing system. Drug interactions are flagged. Clinical questions are answered. Prior authorization is navigated. When a prescriber needs information about a medication's formulary status or a patient needs to understand their regimen, there's a PharmD on the other side of that conversation.

[!KEY] A fintech company processing pharmacy cards doesn't flag a dangerous drug interaction. A PharmD does. Clinical oversight isn't a differentiator we chose — it's what being a pharmacy company actually requires.

Why Free Choice of Pharmacy Matters to Us Personally

James couldn't access his medications because of structural access barriers. That's the exact problem a captive pharmacy card creates when it restricts a patient to a specific network or chain.

Our model is built around the principle that the pharmacy lien follows the patient — not the other way around. Mail order is the default for non-controlled medications: prescriptions are filled and delivered to the client's door, no transportation required, no pharmacy counter to navigate. For controlled substances, travel situations, and urgent same-day fills, the pharmacy card provides retail access through any participating pharmacy.

A patient who has a longstanding relationship with a local pharmacist — who knows their history, their allergies, their family's medications — can maintain that relationship under a LienScripts lien. There is no network lock-in. There is no card that only works at specific locations.

This isn't a policy decision. It's personal. James couldn't fill his prescriptions after his accident. We are not interested in building a product that recreates that barrier for someone else.

For a deeper look at what free choice of pharmacy means under attorney ethics rules, see our post on pharmacy lien free choice and client autonomy. For the mechanics of mail order versus the card, see mail order vs. pharmacy card for injury clients.

What This Means for the Attorneys We Work With

The documentation that comes out of a pharmacy lien program is only as good as the clinical oversight behind it.

A POGOS report — the Pharmacy-Organized General Occurrence Summary that supports a PI demand package — is not a billing statement. It is a clinical document that narrates a patient's medication history through the course of their injury and litigation. It documents the relationship between the injury, the prescriptions, and the ongoing treatment. When a PharmD signs off on a drug utilization review, that signature carries weight in the demand package that a card processor's transaction log does not.

LienScripts invoices, POGOS reports, and drug utilization reviews are built by pharmacists who understand both the clinical side and what plaintiff attorneys need in litigation. The documentation is designed to be used — in demand packages, in negotiations, in depositions.

[!NOTE] Attorneys who have worked with card-first providers often encounter documentation that reads like a receipt. Attorneys who work with LienScripts get documentation that reads like a clinical record. The difference shows up in settlement negotiations.

The Question We Ask Ourselves About Every Feature

Every product decision at LienScripts runs through the same filter: would this have helped James get his medication faster and more reliably after his accident?

That question rules out a lot of the shortcuts that make pharmacy lien programs easier to run at the expense of the patient's experience. It rules out requiring patients to drive to a specific pharmacy when their injuries make that difficult. It rules out automated card processing without clinical oversight. It rules out documentation that serves the provider's reporting needs rather than the attorney's litigation needs.

It points toward mail order as the default. Toward a pharmacy card that handles controlled substances and travel without requiring patients to navigate a new system. Toward pharmacists — not call center staff — answering clinical questions.

[!TIP] Ask your pharmacy lien provider: what's the story behind why you built this? The answer tells you whose interests they're optimizing for — and whether those interests align with your client's.

For the full framework on evaluating pharmacy lien programs from an attorney ethics standpoint, see our post on pharmacy lien free choice and client autonomy.

[!SOURCE] ACPE — Doctor of Pharmacy (PharmD) Degree Program Accreditation — Accreditation Council for Pharmacy Education standards for PharmD degree programs and clinical pharmacy training.

[!SOURCE] NABP — Pharmacist Licensure — National Association of Boards of Pharmacy overview of pharmacist licensing requirements and interstate compacts.